Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies

Bibliographic Details
Main Authors: Carlos Pérez-Plasencia, Teresita Padilla-Benavides, Eduardo López-Urrutia, Alma D. Campos-Parra
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
repurposed drugs
cancer
oncologic therapies
cancer research
clinical insights
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.713040/full
id doaj-2e8fed99a6614ead8e0423d95ed3da47
record_format Article
spelling doaj-2e8fed99a6614ead8e0423d95ed3da472021-06-25T13:54:43ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.713040713040Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic TherapiesCarlos Pérez-Plasencia0Carlos Pérez-Plasencia1Teresita Padilla-Benavides2Eduardo López-Urrutia3Alma D. Campos-Parra4Laboratorio de Genómica Funcional, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, MexicoLaboratorio de Genómica, Instituto Nacional de Cancerología (INCan), Mexico City, MexicoDepartment of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT, United StatesLaboratorio de Genómica Funcional, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, MexicoLaboratorio de Genómica, Instituto Nacional de Cancerología (INCan), Mexico City, Mexicohttps://www.frontiersin.org/articles/10.3389/fonc.2021.713040/fullrepurposed drugscanceroncologic therapiescancer researchclinical insights
collection DOAJ
language English
format Article
sources DOAJ
author Carlos Pérez-Plasencia
Carlos Pérez-Plasencia
Teresita Padilla-Benavides
Eduardo López-Urrutia
Alma D. Campos-Parra
spellingShingle Carlos Pérez-Plasencia
Carlos Pérez-Plasencia
Teresita Padilla-Benavides
Eduardo López-Urrutia
Alma D. Campos-Parra
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
Frontiers in Oncology
repurposed drugs
cancer
oncologic therapies
cancer research
clinical insights
author_facet Carlos Pérez-Plasencia
Carlos Pérez-Plasencia
Teresita Padilla-Benavides
Eduardo López-Urrutia
Alma D. Campos-Parra
author_sort Carlos Pérez-Plasencia
title Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
title_short Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
title_full Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
title_fullStr Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
title_full_unstemmed Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
title_sort editorial: repurposed drugs targeting cancer signaling pathways: clinical insights to improve oncologic therapies
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
topic repurposed drugs
cancer
oncologic therapies
cancer research
clinical insights
url https://www.frontiersin.org/articles/10.3389/fonc.2021.713040/full
work_keys_str_mv AT carlosperezplasencia editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies
AT carlosperezplasencia editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies
AT teresitapadillabenavides editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies
AT eduardolopezurrutia editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies
AT almadcamposparra editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies
_version_ 1721359546075578368

Similar Items